Soluble ST2 does not change cardiovascular risk prediction compared to cardiac troponin T in kidney transplant candidates. by Mira T Keddis, Ziad El-Zoghby, Bruce Kaplan, Jeffrey W Meeusen, Leslie J Donato, Fernando G Cosio, D Eric Steidley

Get full text

Cognitive Impairment in CMV Seropositive and CMV Seronegative Deceased Donor Kidney Transplant Recipients by Maheen Z. Abidi, MD, Xiaomeng Chen, MSPH, Yi Liu, ScM, Nadia M. Chu, PhD, Aarti Mathur, MD, PhD, Adriana Weinberg, MD, Bruce Kaplan, MD, Silas Norman, MD, Jingyao Hong, MHS, Dorry L. Segev, MD, PhD, Kristine M. Erlandson, MD, Mara A. McAdams-DeMarco, PhD

Get full text

Thoracoabdominal Normothermic Regional Perfusion: Real-world Experience and Outcomes of DCD Liver Transplantation by Yanik J. Bababekov, MD, MPH, Anna H. Ha, BA, Trevor L. Nydam, MD, Carlos Goncalves, PhD, Rashikh Choudhury, MD, JoLynn Shinsako, PA-C, Maria Baimas-George, MD, MPH, David M. Reynolds, MD, Cassidy Yoshida, BA, Caroline A. Racke, MPH, Han Grewal, MD, MBA, Sophia Pomposelli, Ivan E. Rodriguez, MD, Jordan R.H. Hoffman, MD, MPH, Jesse D. Schold, PhD, MStat, MEd, Bruce Kaplan, MD, Elizabeth A. Pomfret, MD, PhD, James J. Pomposelli, MD, PhD

Get full text